Ayub Khattak - Cue Health President, CoFounder
Insider
Ayub Khattak is President, CoFounder of Cue Health
| Age | 39 |
| Phone | 858 412 8151 |
| Web | https://www.cuehealth.com |
Ayub Khattak Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ayub Khattak against Cue Health stock is an integral part of due diligence when investing in Cue Health. Ayub Khattak insider activity provides valuable insight into whether Cue Health is net buyers or sellers over its current business cycle. Note, Cue Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cue Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ayub Khattak over a year ago Disposition of 10742 shares by Ayub Khattak of Cue Health at 0.25 subject to Rule 16b-3 |
Cue Health Management Efficiency
The company has return on total asset (ROA) of (0.308) % which means that it has lost $0.308 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9457) %, meaning that it created substantial loss on money invested by shareholders. Cue Health's management efficiency ratios could be used to measure how well Cue Health manages its routine affairs as well as how well it operates its assets and liabilities.Cue Health currently holds 47.94 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cue Health has a current ratio of 2.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cue Health's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Nicolette Sherman | Certara | 54 | |
| Jona Raasch | National Research Corp | 65 | |
| Kristi Lane | Healthcare Triangle | N/A | |
| Andy Brailo | Premier | N/A | |
| CPA CPA | National Research Corp | 66 | |
| Helen Hrdy | National Research Corp | 60 | |
| Paul Horstmeier | Health Catalyst | 63 | |
| Ryan Bond | Aclarion | 52 | |
| Tyson Murdock | HealthEquity | 53 | |
| Suresh Venkatachari | Healthcare Triangle | 57 | |
| Mark Grove | Forian Inc | N/A | |
| Wei Chen | EUDA Health Holdings | 40 | |
| Andrew Douglas | Forian Inc | N/A | |
| Jason Alger | Health Catalyst | 41 | |
| , PharmD | Certara | N/A | |
| Michael Vesey | Forian Inc | 62 | |
| Steven Sobak | EUDA Health Holdings | 78 | |
| Jaap Mandema | Certara | N/A | |
| Max Wygod | Forian Inc | 37 | |
| Jon Boumstein | National Research Corp | N/A | |
| Jason Jones | Health Catalyst | N/A | |
Management Performance
| Return On Equity | -0.95 | |||
| Return On Asset | -0.31 |
Cue Health Leadership Team
Elected by the shareholders, the Cue Health's board of directors comprises two types of representatives: Cue Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cue. The board's role is to monitor Cue Health's management team and ensure that shareholders' interests are well served. Cue Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cue Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erica Esq, General Secretary | ||
| Lorna Williams, Vice Relations | ||
| Allison Blackwell, Chief Officer | ||
| David Arida, Chief Officer | ||
| Ayub Khattak, President, CoFounder | ||
| Nitin Duggal, Chief Officer | ||
| John Gallagher, Chief Officer | ||
| Dena Cook, Chief Officer | ||
| Clint Sever, CoFounder Officer | ||
| Aasim Javed, Treasurer CFO | ||
| Eileen Sheil, Chief Officer | ||
| Randall Pollard, Controller Officer | ||
| David MD, Chief Officer | ||
| Christopher Achar, Chief Director | ||
| Suzanne Stone, Chief Officer |
Cue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cue Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.95 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (4.38) % | |||
| Current Valuation | 5.46 M | |||
| Shares Outstanding | 159.09 M | |||
| Shares Owned By Insiders | 11.56 % | |||
| Shares Owned By Institutions | 52.80 % | |||
| Number Of Shares Shorted | 776.46 K | |||
| Price To Earning | 16.86 X | |||
| Price To Book | 0.10 X |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Cue Stock
If you are still planning to invest in Cue Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cue Health's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Directory Find actively traded commodities issued by global exchanges |